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Edited by Hans-Dieter KlenkAbstract The a-amino-3-hydroxy-5-methyl-4-isoxazoleprop-
ionic acid (AMPA) class of ionotropic glutamate receptors com-
prises four diﬀerent subunits: iGluR1/iGluR2 and iGluR3/
iGluR4 forming two subgroups. Three-dimensional structures
have been reported only of the ligand-binding core of iGluR2.
Here, we present two X-ray structures of a soluble construct of
the R/G unedited ﬂip splice variant of the ligand-binding core
of iGluR4 (iGluR4i(R)-S1S2) in complex with glutamate or
AMPA. Subtle, but important diﬀerences are found in the li-
gand-binding cavity between the two AMPA receptor subgroups
at position 724 (Tyr in iGluR1/iGluR2 and Phe in iGluR3/
iGluR4), which in iGluR4 may lead to displacement of a water
molecule and hence points to the possibility to make subgroup
speciﬁc ligands.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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a-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors belong to the family of ionotropic gluta-
mate receptors (iGluRs) and are the primary mediators of fast
synaptic transmission in the central nervous system [1] and
show a broad distribution. These receptors engage in regula-
tion of synaptic strength, a mechanism putatively underlying
learning and memory [2]. However, AMPA receptors are also
implicated in a number of neurological diseases [3].Abbreviations: AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazoleprop-
ionic acid; Br-HIBO, (S)-a-amino-4-bromo-3-hydroxy-5-isoxazole-
propionic acid; Cl-HIBO, (S)-a-amino-4-chloro-3-hydroxy-5-
isoxazolepropionic acid; CPW399, (S)-2-amino-3-(1,3,5,6,7-pentahy-
dro-2,4-dioxocyclopenta[e] pyrimidin-1-yl)propanoic acid; iGluR,
ionotropic glutamate receptor; iGluR2i(R)-S1S2J, ligand-binding core
of the R/G unedited ﬂip splice variant of iGluR2; iGluR2o(G)-S1S2J,
ligand-binding core of the R/G edited ﬂop splice variant of iGluR2;
iGluR4i(R)-S1S2, ligand-binding core of the R/G unedited ﬂip splice
variant of iGluR4
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doi:10.1016/j.febslet.2008.11.005AMPA receptors are composed of four types of subunits,
designated iGluR1-iGluR4. Most, if not all, AMPA receptors
form heterotetramers, consisting of symmetric dimer-of-dimers
of iGluR2 and either iGluR1, iGluR3 or iGluR4, and the stoi-
chiometry of subunits has been shown to determine channel
function and receptor traﬃcking [4]. The ligand-binding core
is present in the extracellular part of the receptors and consists
of two domains D1 and D2. Upon binding of an agonist, these
two domains move towards each other, leading to opening of
the ion channel pore; a so-called Venus-ﬂytrap mechanism [5].
Alternative splicing and RNA editing within the ligand-
binding core of AMPA receptors further modiﬁes receptor
function. Flip/ﬂop alternative splicing of 38 amino acids in
the S2 segment prior to the third transmembrane region cre-
ates a range of functional AMPA receptor subunits that enable
modulation of the rate of desensitization and recovery from
desensitization [1]. Similar eﬀects have been demonstrated for
RNA editing at the R/G site preceding the splice variant region
[6,7].
To further study the functional role of diﬀerent AMPA
receptors, compounds that selectively target individual sub-
units are essential. Today, compounds are available that selec-
tively target either iGluR1/iGluR2 or iGluR3/iGluR4 [8–12].
The structure determination of a ligand-binding core construct
of iGluR2 [5] has stimulated numerous structural and func-
tional studies on this receptor. However, until now the other
three AMPA receptor subunits have not been subjected to
structure determination. Here, we present two X-ray structures
of the ligand-binding core of the R/G unedited form of the ﬂip
splice variant of iGluR4 (iGluR4i(R)-S1S2) with bound gluta-
mate or AMPA. These structures allow a detailed analysis of
structural similarities and dissimilarities within the AMPA
receptor family, which may be of importance for receptor func-
tion and ligand selectivity.2. Materials and methods
2.1. Expression and puriﬁcation of iGluR4i(R)-S1S2
The S1 and S2 segments constituting the iGluR4i(R)-S1S2 were
polymerase chain reaction (PCR)-ampliﬁed from full-length iGluR4
using the primers: S1-forward: ctcggatcccgtggcagaacagtggttgtaaccac;
S1-reverse: tatgggggtaccttttttgatcatgatagagatg; S2-forward: caaaaaag-
gtacccccatagaaagtgcagaagacc and S2-reverse: gctgtgctcgagttatccacatt-
cacctttatcgta. PCR-products were digested with restriction enzymes
and ligated into pET-32a(+) (Novagen, WI, USA). The protein wasblished by Elsevier B.V. All rights reserved.
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oredoxin fusion protein of ca. 47 kDa. An overnight culture was grown
in HyperBroth + glucose nutrient mix (Athenaes, MD, USA) at 30 C
to an OD600 of ca. 2 before induction with 0.2 mM isopropyl-b-D-thio-
galactopyranoside. Protein was expressed overnight at 25 C.
After cell harvesting and centrifugation, the fusion protein was puri-
ﬁed on a HisTrap FF column (GEHealthcare Life Sciences, Hørsholm,
Denmark) and eluted with 50 mM sodium phosphate pH 7.4, 0.5 M so-
dium chloride and 0.5 M imidazole. Two trypsin cleavage sites between
thioredoxin and iGluR4i(R)-S1S2 are present in the fusion protein,
which upon digestion with trypsin in 50 mM sodium phosphate pH
6.5, 20 mM sodium chloride, 1 mM glutamate and 2 mM magnesium
chloride at room temperature results in a protein of ca. 33 kDa and
the intended iGluR4i(R)-S1S2 of ca. 29 kDa. The digested 29 kDa con-
struct contains an N-terminal glycine, the S1 segment [415-
RTIV. . .MIKK-528], a Gly-Thr linker and the S2 segment [654-
PIES. . .GECG-796]. Subsequently, the protein was puriﬁed on a Hi-
Trap SP HP column (GE Healthcare Life Sciences) at 6 C using
50 mM sodium phosphate pH 6.0, 1 M sodium chloride and 1 mM
EDTA as elution buﬀer. A ﬁnal puriﬁcation step was done on a Super-
dex 75 HR column 10/30 (GE Healthcare Life Sciences) and the protein
was eluted with 20 mM HEPES pH 7.0 and 10 mM sodium chloride.
2.2. Crystallization and data collection
iGluR4i(R)-S1S2 was crystallized with either (S)-glutamate or (S)-
AMPA, using the hanging drop vapour diﬀusion method at 6 C and
drops of 1 + 1 ll. For crystallization of iGluR4i(R)-S1S2 with gluta-
mate, the 10.5 mg/ml protein solution consisted of 20 mM HEPES
pH 7.0, 10 mM sodium chloride and 1 mM glutamate and the crystal-
lization buﬀer consisted of: 18% polyethylene glycol (PEG) 4000,
0.3 M ammonium sulfate and 0.1 M sodium acetate pH 5.5. For crys-
tallization of iGluR4i(R)-S1S2 with AMPA, the 8.3 mg/ml protein
solution consisted of 20 mM HEPES pH 7.0, 10 mM sodium chloride
and 10 mM AMPA and the crystallization buﬀer consisted of: 13%
PEG4000, 0.4 M ammonium sulfate and 0.1 M sodium acetate pH 5.5.
Before data collections at beamline 911, MAX-Lab, Lund, Sweden,
the crystals were cryo-cooled using glycerol. Two data sets were col-
lected to 1.4 and 1.9 A˚ resolution of iGluR4i(R)-S1S2 in complex with
glutamate and AMPA, respectively (Table 1). The data were processed
using MOSFLM [13] and SCALA within the CCP4 package [14].
2.3. X-ray structure determinations and analysis
Both structures were solved by molecular replacement using PHA-
SER within CCP4. The structure of iGluR2-S1S2J in complex with
glutamate (molA, pdb-code 1FTJ, poly-Ala) was used as the input
structure in the case of iGluR4 with glutamate and the latter structure
(molA) for iGluR4 with AMPA. Automated model building was per-
formed with ARP/wARP implemented in CCP4 and further model
building was done using program COOT [15]. For iGluR4i(R)-S1S2
with glutamate, reﬁnements were performed with the program REF-
MAC5 in CCP4. The structure of iGluR4i(R)-S1S2 with AMPA was
reﬁned using PHENIX [16]. Both structures were validated in PRO-Table 1
Crystallographic and structural information on iGluR4i(R)-S1S2.
Data collection Glutamate
Space group P21
Cell parameters (A˚, ) 47.4, 105.2, 66
Wavelength (A˚) 1.0412
Resolution limits (A˚) 27.75–1.40(1.4
Completeness (%) 98.1(100.0)
Redundancy 3.6(3.2)
Rmerge (%) 9.2(40.5)
I/rI 11.3(2.3)
Reﬂections used/Rfree 123064/1250(1
Reﬁnement
Bond length mean deviation (A˚) 0.009
Bond angle mean deviation () 1.23
Rwork (%) 16.7
Rfree (%) 18.3
aValues between parentheses refer to the last resolution shell.CHECK [17]. For statistics on reﬁnement, see Table 1. Ligand-induced
domain closures were calculated using DynDom [18]. The CCP4 pro-
gram CONTACTS was used in the analysis of protein–ligand and pro-
tein–protein interactions. The program PyMOL [19] was used for the
preparation of ﬁgures.
2.3.1. Protein data bank accession number. The atomic coordinates
and structure factors of iGluR4i(R)-S1S2 with bound glutamate and
AMPA, respectively, have been deposited in the Protein Data Bank
under the accession codes 3FAS and 3FAT.
2.4. Binding aﬃnity
The binding aﬃnities of (S)-glutamate and (RS)-AMPA at the
iGluR4i(R)-S1S2 soluble construct were determined by a radioligand
binding competition assay. Puriﬁed construct (0.1–0.2 lg protein)
was incubated with 4–6 nM (RS)-[5-methyl-3H]-AMPA (40.0 Ci/
mmol; Perkin–Elmer, Boston, MA) in the presence of 0.1 nM–
0.10 mM competitor for 1.5–2 h on ice in 250 ll assay buﬀer (50 mM
Tris–HCl, 100 mM KSCN, 2.5 mM CaCl2, pH 7.2 at 4 C; containing
10% glycerol (v/v)). Samples were ﬁltered onto Millipore (Billerica,
MA) 0.22 lm GSWP nitrocellulose ﬁlters, washed twice with 1.5 ml
ice-cold assay buﬀer and radioactivity determined by scintillation
counting. Data were analyzed using Graﬁt (Erithacus Software Ltd.,
Horley, UK) and ﬁt as previously described [20] to determine Hill coef-
ﬁcient and Ki, where Ki = Kd in the case of (RS)-AMPA.3. Results
3.1. Glutamate and AMPA binding aﬃnities for iGluR4i(R)-
S1S2
The binding aﬃnities (Ki, mean ± SEM) of (RS)-AMPA
(22.8 ± 1.5 nM, n = 4) and (S)-glutamate (171 ± 18 nM,
n = 3) at iGluR4i(R)-S1S2 (Fig. 1) were comparable to those
previously reported at full-length iGluR4o(R) (40 nM and
354 nM, respectively; [21]).
3.2. iGluR4i(R)-S1S2 crystal structures
To investigate structural diﬀerences among AMPA receptors
and diﬀerences in binding of ligands, we determined two high-
resolution X-ray structures of iGluR4i(R)-S1S2: one as a com-
plex with glutamate (1.4 A˚ resolution) and one with AMPA
(1.9 A˚ resolution). The structure of iGluR4i(R)-S1S2 with glu-
tamate contains two molecules (molA and molB) within the
asymmetric unit of the crystal, whereas the structure with
AMPA has three molecules (molA-molC) within the asymmet-
ric unit. In both structures, all molecules are engaged in dimer
formation (Fig. 2A), and the symmetrical dimer is similar toAMPA
C2
.5 b = 97.2 105.2, 169.5, 73.9 b = 120.6
1.0412
8–1.40)a 33.17–1.90(2.00–1.90)
99.8(100.0)
3.7(3.7)
7.5(37.6)
12.4(3.7)
%) 87195/4371(5%)
0.005
0.88
17.5
21.6
Fig. 1. Competition binding of (S)-glutamate and (RS)-AMPA at
iGluR4i(R)-S1S2. Shown is one competition experiment (conducted in
triplicate, replicated 3–4 times) for each ligand. s, (S)-glutamate; d,
(RS)-AMPA.
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This similarity also applies to the individual residues compris-
ing the dimer interface and to inter-domain contacts.
The R/G editing site is located at the top of the dimer inter-
face (Fig. 2A), and the conformation and interactions of the
Arg765 side chain in iGluR4 with Arg765 from the other sub-
unit and surrounding acidic residues are as seen in the ligand-
binding core construct of the R/G unedited ﬂip splice variant
of iGluR2 (iGluR2i(R)-S1S2J) [22]. In brief, the two Arg765
side chains are pointing towards each other (Fig. 2A) with
counter-charges coming from Glu508 and Asp512. In the
structure of iGluR4i(R)-S1S2 with glutamate, a sulfate ion is
located in vicinity of Arg765 and forms a salt bridge to the
Ng2 atom of Arg765. Also, the ﬂip splice variant region in
the C-terminal part of the S2 segment (Fig. 2) are very similar,
with water-mediated hydrogen bonds only being formed from
Ser776 to the neighbouring subunit.
3.3. Structural diﬀerences among AMPA receptors
An alignment of amino acid residues comprising the ligand-
binding cores of iGluR1-iGluR4 is shown in Fig. 2B. It is seen
that 48 amino acids diﬀer among all four subunits of which 20
vary between iGluR4 and iGluR2. By comparing the struc-
tures of iGluR4 and iGluR2, it emerges that these residues
are primarily either facing solvent or taking part in formation
of hydrophobic cores within both domains D1 and D2. Of
note, ﬁve residues are pair-wise conserved between iGluR3
and iGluR4 on the one hand and iGluR1 and iGluR2 on the
other hand, i.e. Y689F, T705V, F722Y, F724Y and V756I
(Fig. 2A and B). Tyr689 in iGluR4 is located ca. 15 A˚ from
the glutamate binding site and the side chain is engaged in
water-mediated hydrogen bonds only. Thr705 is forming a di-
rect hydrogen bond to the carbonyl oxygen atom of Thr707,
which may stabilize this region harbouring the D1–D2 inter-
domain lock residue Thr708 (Fig. 3C). Val756 is pointing to-
wards a hydrophobic core in domain D1. The most important
diﬀerences seem to be at positions 722 and 724. Phe724 in
iGluR4 is located ca. 6 A˚ from the isoxazole ring system of
AMPA and ca. 4 A˚ from the phenyl group of Phe722. Both
residues are tyrosine in iGluR2, which allow the formationof water-mediated hydrogen bonds from the ligands to the cor-
responding Tyr723 in iGluR2 but not in iGluR4 (see Section
3.4).
3.4. Binding modes in iGluR4i(R)-S1S2
The binding modes of glutamate and AMPA in iGluR4i(R)-
S1S2 are similar to those in the ligand-binding core of the R/G
edited ﬂop splice variant of iGluR2 (iGluR2o(G)-S1S2J) [5].
Whereas the hydrogen-bonding pattern from glutamate to
iGluR4 (Fig. 3A) is almost the same as in iGluR2, diﬀerences
are observed in the ligand-binding sites with AMPA bound
(Fig. 3B and C). The water molecule bridging Tyr723 and
the ligand in iGluR2o(G)-S1S2J is absent in the structure of
iGluR4i(R)-S1S2 with AMPA. This results in local conforma-
tional changes in iGluR4 compared to iGluR2, involving pri-
marily residues Leu672 and Thr708. The side chain of
Leu672 points towards Phe724 creating a distance of ca. 4 A˚
between the two residues. In addition, the inter-domain lock
residue Thr708 adopts a diﬀerent conformation to optimize
contacts with Leu672, Phe724 and Met730. In the structure
of iGluR4i(R)-S1S2 with glutamate this water molecule is still
present but does not form a direct hydrogen bond to the li-
gand. Finally, Met730 undergoes an induced ﬁt in iGluR4i
(R)-S1S2 (not shown), depending on the ligand bound as pre-
viously observed in iGluR2o(G)-S1S2J [23].
As no structure is yet available of the apo form of iGluR4i
(R)-S1S2, D1–D2 domain closures have been calculated rela-
tive to the apo structure of iGluR2o(G)-S1S2J (pdb-code
1FTO, molA). Glutamate induces a domain closure of 20.6–
20.8 in iGluR4i(R)-S1S2, which is similar to the domain clo-
sures seen in iGluR2o(G)-S1S2J (pdb-code 1FTJ: 19.1–21.1)
and iGluR2i(R)-S1S2J (pdb-code 2UXA: 18.4–21.0). Of note,
AMPA introduces a larger domain closure in iGluR4i(R)-S1S2
(22.9–23.5) than in iGluR2o(G)-S1S2J (pdb-code 1FTM:
21.1–21.4), which leads to a considerably larger distance
between residues in the vicinity of the Gly-Thr S1–S2 linker
region from two neighbouring iGluR4 molecules (40 A˚ versus
36 A˚ between Ca atoms of two Ile655 residues). The location
of the linkers is indicated in Fig. 2A.4. Discussion
AMPA receptors display an overall sequence identity of 82%
within the ligand-binding cores (Fig. 2B). However, the amino
acid diﬀerences allow ﬁne tuning of receptor function and also
provide opportunities to speciﬁcally target a given subunit with
agonists and antagonists. The structures of the ligand-binding
core of the R/G unedited form of the ﬂip splice variant of
iGluR4 presented here may stimulate structure-based drug de-
sign of compounds that target speciﬁc AMPA receptor sub-
types.
Compounds have been reported that show selectivity
towards iGluR1/iGluR2 compared to iGluR3/iGluR4,
e.g. (S)-a-amino-4-bromo-3-hydroxy-5-isoxazolepropionic
acid (Br-HIBO): Ki = 250 nM (iGluR2(R)o) and 11700 nM
(iGluR4o) [11], (S)-a-amino-4-chloro-3-hydroxy-5-isoxazole-
propionic acid (Cl-HIBO): Ki = 370 nM (iGluR2(R)o) and
11,900 nM (iGluR4o) [11] and (S)-2-amino-3-(1,3,5,6,7-penta-
hydro-2,4-dioxocyclopenta[e] pyrimidin-1-yl)propanoic acid
(CPW399): Ki = 223 nM (iGluR2(R)o) and 2,090 nM
Fig. 2. The ligand-binding core of iGluR4 forms a dimer. (A) Schematic drawing of the dimeric structure of iGluR4i-S1S2 in complex with
glutamate. MolA is shown in light blue and molB in blue. Glutamate is shown in space-ﬁlling representation. Amino acid residues diﬀering between
iGluR4 and iGluR2 are shown in grey stick representation. The ﬁve residues in iGluR4 diﬀering between the two AMPA receptor subgroups iGluR1/
iGluR2 and iGluR3/iGluR4 are shown in green. The R/G editing site is high-lighted in orange and the ﬂip splice variant region in yellow. The linker–
linker distance between two Ile655 residues is shown by a dotted line. (B) Alignment of S1 and S2 segments of R/G unedited ﬂip splice variants of
iGluR1–iGluR4. Positions of amino acid diﬀerences are high-lighted using grey boxes and residues diﬀering between iGluR4 and iGluR2 for which
structures are available are shown by a grey star. Amino acid residues of iGluR4 forming direct hydrogen bonds to glutamate and AMPA are marked
by a blue box. Protein residues that might be of importance for iGluR1/iGluR2 versus iGluR3/iGluR4 selectivity are marked by a red star and the
residues have been coloured red and green, respectively. The R/G editing site is high-lighted by an orange box and the splice variant region by yellow
boxes. The extra glycine at the N-terminal end of iGluR4 is marked with a purple box.
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S1S2 it is most likely that the iGluR4 selectivity can be attrib-
uted to the diﬀerent type of amino acid present at position 724;
i.e. a tyrosine in iGluR1/iGluR2 and a phenylalanine in
iGluR3/iGluR4. When comparing the structures of iGluR4i
(R)-S1S2 with AMPA and glutamate, one major diﬀerence isthe absence of a water molecule in the vicinity of Phe724 in
the structure with AMPA. In iGluR2o(G)-S1S2J, this water
molecule is present in both the complexes with glutamate
and AMPA [5]. Displacement of this water molecule does
not seem to have a signiﬁcant eﬀect on the binding aﬃnity of
AMPA for iGluR4o (Ki = 40 nM [11]) as compared to that at
Fig. 3. Binding of agonists to the ligand-binding core of iGluR4. (A) Fo-Fc omit electron density map contoured at 3 sigma and hydrogen-bonding
interactions (stippled lines) of glutamate to iGluR4 (molA) and water molecules (displayed as red spheres). (B) As in panel A, but with AMPA as
ligand. (C) Comparison of the binding mode of AMPA in iGluR4 (grey; molA) and iGluR2 (green; pdb-code 1FTM, molA). The water-mediated
hydrogen-bonding network from AMPA to Tyr723 in iGluR2 is shown as dotted lines; this network is missing in iGluR4 as the corresponding
residue is Phe724. In addition, the D1–D2 inter-domain lock Glu424-Thr708 is high-lighted.
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(iGluR4i(R)-S1S2: Ki = 23 nM and iGluR2o(G)-S1S2J:
Ki = 13 nM) [25]. Therefore, the presence of the water molecule
presumably is not critical for AMPA binding. However, it has
previously been shown that the selectivity of Br-HIBO and
CPW399 can be attributed to the presence of this water mole-
cule, forming a hydrogen-bonding network from the ligands to
Tyr723 in iGluR2o(G)-S1S2J [25,26]. This water network was
shown to be absent in the Tyr723Phe mutant structures of
iGluR2o (G)-S1S2J with the same two ligands, and it was pro-
posed as an explanation for the diﬀerence in binding aﬃnity
observed at iGluR2o(G)-S1S2J (Br-HIBO: 500 nM [25] and
CPW399: 393 nM [26]) and the mutant (Br-HIBO: 9200 nM
[25] and CPW399: 3330 nM [26]). Hence, like in the iGluR2
mutant the absence of a water molecule in the vicinity of
Phe724 may be critical for binding of ligands in the binding
core of iGluR4 and may explain the diﬀerence in selectivity of
Br-HIBO, Cl-HIBO and CPW399. However, additional
experiments are required to fully clarify the mechanism
underlying the selectivity of iGluR2 over iGluR4 preferring
ligands.
The dimer interface, including the R/G editing site and
ﬂip/ﬂop splice variant region, is strikingly similar in the li-
gand-binding cores of iGluR2 and iGluR4. This similarity
may hamper development of allosteric modulators that selec-
tively target the dimer interface of individual AMPA recep-tors. The presence of similar dimer interfaces is also in
agreement with the observation that the desensitization
properties of AMPA receptors are alike [27], as rearrange-
ments of the dimer interface are thought to lead to receptor
desensitization [28,29]. Interestingly, AMPA induces a ca. 2
larger D1–D2 domain closure in iGluR4i(R)-S1S2 than in
iGluR2o(G)-S1S2J. This leads to a ca. 4 A˚ larger separation
between the linker region of two subunits (connecting both
the S1 and S2 segments of the ligand-binding core to the
transmembrane part). However, further structural and func-
tional studies are required to fully establish the signiﬁcance
of this observation.
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